Expression of Human Cu-Zn Superoxide Dismutase Gene in Transgenic Mice: Model for Gene Dosage Effect in Down Syndrome

References

• Fridovich I. Superoxide dismutases. Advance in Enzymology 1974; 41: 35–97
   PubMedGoogle Scholar
• Sinet P. M. Metabolism of oxygen derivatives in Down's Syndrome. Annals of New York Academy of Sciences 1982; 396: 83–94
   PubMed Web of Science ®Google Scholar
• Elroy-Stein O., Bernstein Y., Groner Y. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO Journal 1986; 5: 615–622
   PubMed Web of Science ®Google Scholar
• Elroy-Stein O., Groner Y. Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu-Zn superoxide dismutase: implication for gene dosage effects in Down's Syndrome. Cell. 1988; 52: 259–267
   PubMed Web of Science ®Google Scholar
• Ball M. J., Nutall K. Neurofibrillary tangles, granulovacuolar degeneration. and neuron loss in Down's Syndrome: quantitative comparison with Alzheimer's dementia. Annals in Neurology 1980; 7: 462–465
   PubMed Web of Science ®Google Scholar
• Lott I. T. Down's Syndrome aging, and Alzheimer's disease: a clinical review. Annals of New York Academy of Science 1982; 396: 15–27
   PubMed Web of Science ®Google Scholar
• Ceballos I., Delabar J. M., Nicole A., Lynch R. E., Hallewel R. A., Kamoun P., Sinet P. M. Expression of transected human CuZn superoxide dismutase gene in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochemical el Biophysica Acta 1988; 949: 58–64
   PubMed Web of Science ®Google Scholar
• Puppo A., Halliwell B. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Biochemical Journal 1988; 249: 185–190
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge M. C. Oxygen radicals and the nervous system. Trends in Neuros-cience 1985; 8: 22–26
   Web of Science ®Google Scholar
• Avraham K. B., Schickler M., Sapoznikow D., Yarom R., Groner Y. Down's Syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn superoxide dismutase. Cell 1988; 54: 823–829
   PubMed Web of Science ®Google Scholar
• Delacourte A., Defossez A., Ceballos I., Nicole A., Sinet P. M. Preferential localization of copper-zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's disease. Neuros-cience Leffers 1988; 92: 247–253
   PubMed Web of Science ®Google Scholar
• Zemlan F. P., Thienhaus O. J., Bosmann H. B. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Bruin Research 1989; 476: 160–162
   PubMed Web of Science ®Google Scholar
• Hallewell R. A., Puma J. P., Mullenbach G. T., Najarian R. C. Structure of the human Cu-Zn SOD gene. Superoxide Dismutase in Chemistry, Biology and Medecine, G. Rotilio. Elsevier Science Publ. 1986; 249–256
   Google Scholar
• Sherman L., Dafni N., Lieman-Hunvitz J., Groner Y. Nucleotide sequence and expression of human chromosome 21 -encoded superoxide dismutase mRNA. Proceedings of the National Academy of Sciences USA 1983; 80: 5465–5469
   PubMed Web of Science ®Google Scholar
• Moroy T., Etiemble J., Trepo C., Tiollais P., Buendia N. A. Transcription of woodchuck hepatitis virus in the chronically infected liver. EMBO Journal 1985; 4: 1507–1510
   PubMedGoogle Scholar
• Carmagnol F., Sinet P. M., Rapin J., Jerome H. Glutathione-S-trdnsferase of human red blood cells; assay, values in normal subjects and two pathological circumstances: hyperbilirubinemia and impaired renal function. Clinical Chemical Acta 1981; 117: 209–217
   PubMed Web of Science ®Google Scholar
• Carlberg I., Mannervick B. Glutathione reductase. Methods in Enzymology 1985; 113: 484–490
   PubMed Web of Science ®Google Scholar
• Flament S., Delacourte A. Abnormal Tau species are produced during Alzheimer's disease neurodegenerating process. FEES Lettcers 1989; 247: 213–216
   PubMedGoogle Scholar
• Lee G., Cowan N., Kirschner M. The primary structure and heterogeneity of Tau proteins from mouse brain. Science 1988; 239: 285–288
   PubMedGoogle Scholar
• Delacourte A., Defossez A. Alzheimer's disease: Tau proteins. the promoting factors of microtubule assembly. are major components of pired helical filaments. Journal of he Neurological Sciences 1986; 76: 173–186
   PubMed Web of Science ®Google Scholar
• Schickler M., Knobler H., Avraham K. B., Elroy-Stein O., Groner Y. Diminished serotonin uptake in platelets of transgenic mice with increased CuZn superoxide dismutase activity. EM BO Journal 1989; 8: 1385–1392
   PubMed Web of Science ®Google Scholar
• Ceballos I., Javoy-Agid F., Delacourte A., Dcfossez A., Nicole A., Sinet P. M. Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency?. Antioxidants in Therapy and Preventive Medecine, I. Emerit, L. Packer, C. Auclair. Plenum Press. 1989
   Google Scholar
• Sinet P. M., Michelson A. M., Bazin A., Lejeune J., Jerome H. Increase in glutathione peroxidase activity in erythrocytes from tiresome 21 subjects. Biochemistry and Biophysical Research Communications 1975; 67: 910–915
   PubMed Web of Science ®Google Scholar
• Anneren G., Edquist L. E., Gebre-Medhin M., Gustavson R. H. Glutathione peroxidase activity in erythrocytes in Down's syndrome. Abnormal variations in relation to age and sex through childhood and adolescence. trilogy 1985; 21(I)9–17
   Google Scholar
• Brroksbank B. W. L., Balazs R. Superoxide dismutase, glutathione peroxidase and lip-operoxidaiton in Down's Syndrome fetal brain. Development in Brain Research 1984; 16: 37–44
   Google Scholar
• Anneren K. G., Epstein C. J. Lipid peroxidation and superoxide dismutase-l and glutathione peroxidase activities in trisomy 16 fetal mice and human trisomy 21 fibroblasts. Pediatric Research 1987; 21: 88–92
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I., Iqbal K., Quintana N., Tung Y. C., Zaidi M. S., Wisniewski H. M. Microtubule-associated protein Tau, a component of Alzheimer's paired helical filaments. Journal of Biological Chemistry 1986; 261: 6084–6089
   PubMed Web of Science ®Google Scholar
• Kosik K. S., Joachim C. L., Selkoe D. J. Microtubule-associated protein Tau is a major antigenic component of paired helical filaments in Alzheimer's disease. Proceedings of the National Academy of Sciences USA 1986; 83: 4044–4048
   PubMed Web of Science ®Google Scholar
• Montejo D. E., Garcini E., CarrasGsa J. L., Correas I., Nieto A., Avila J. Tau factor polymers are similar to paired helical filaments of Alzheimer's disease. FEBS Letters 1988; 236: 150–154
   PubMedGoogle Scholar